ISPOR
ISPOR (International Society for Pharmacoeconomics and Outcomes Research) is a non-profit professional organization that focuses on the research and application of pharmacoeconomics and health outcomes research. The society's mission is to promote health economics and outcomes research excellence to improve decision making for health globally.
History[edit | edit source]
ISPOR was founded in 1995 to provide a platform for healthcare professionals to share their research and knowledge in the field of pharmacoeconomics and health outcomes. The society has grown significantly since its inception, with members from over 120 countries.
Mission and Vision[edit | edit source]
ISPOR's mission is to promote health economics and outcomes research excellence to improve decision making for health globally. The society's vision is to be the leading global scientific and educational organization for health economics and outcomes research.
Activities[edit | edit source]
ISPOR organizes annual meetings, regional conferences, and educational webinars to facilitate the exchange of knowledge and ideas among its members. The society also publishes the Value in Health journal, which features articles on health economics, health policy, and health outcomes research.
Membership[edit | edit source]
ISPOR offers various types of membership, including individual, student, and institutional memberships. Members have access to a wide range of resources, including the Value in Health journal, educational webinars, and networking opportunities.
Impact[edit | edit source]
ISPOR has made significant contributions to the field of pharmacoeconomics and health outcomes research. The society's research and publications have influenced health policy decisions and improved patient outcomes worldwide.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
